{"id":"W4362458210","doi":"10.4244/eij-d-22-01006","title":"A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trial.","year":2023,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Abbott Vascular; MicroPort; Servier; Novo Nordisk; Mylan; Boston Scientific Corporation; Canada Excellence Research Chairs, Government of Canada; Alnylam Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Edwards Lifesciences; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Clinical endpoint; Myocardial infarction; Discontinuation; Internal medicine; Aspirin; P2Y12; Adverse effect; Platelet aggregation inhibitor; Population; Stent; Acute coronary syndrome; Surgery; Clopidogrel; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009801826,0.002950093,0.005088144,0.0006687285,0.0006748787,0.001394729,0.0009511065,0.002428207,0.006754858],"category_scores_gemma":[0.006505518,0.001255822,0.003039873,0.001018506,0.001657661,0.001109328,0.0006796392,0.002654814,0.001518387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005824341,"about_ca_system_score_gemma":0.001839685,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004945835,"about_ca_topic_score_gemma":0.0009077563,"domain_scores_codex":[0.9948388,0.003553548,0.0004593461,0.0005122541,0.0002870691,0.0003489652],"domain_scores_gemma":[0.9957736,0.001818928,0.0007866777,0.0004216123,0.0003885693,0.0008106439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9851856,0.005293038,0.001135217,0.0008841493,0.001033522,0.00002860053,0.00004361552,0.0001984192,0.001355087,0.0002280774,0.0002330479,0.004381645],"study_design_scores_gemma":[0.8753642,0.1191004,0.002121955,0.00006331208,0.001438474,0.00003456759,0.00002051866,0.0002437629,0.0002845876,0.0002177633,0.001089641,0.00002079703],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.8688788,0.02240564,0.00665671,0.001732376,0.002459991,0.08660063,0.004377058,0.0001694976,0.006719254],"genre_scores_gemma":[0.8725867,0.008093328,0.01380447,0.002921083,0.003152704,0.09082889,0.003396616,0.00005109819,0.005165068],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.009801826,"threshold_uncertainty_score":0.05183762,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03024804863319197,"score_gpt":0.24111669439305,"score_spread":0.2108686457598581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}